Bottom-up design and synthesis of limit size lipid nanoparticle systems with aqueous and triglyceride cores using millisecond microfluidic mixing.

Limit size systems are defined as the smallest achievable aggregates compatible with the packing of the molecular constituents in a defined and energetically stable structure. Here we report the use of rapid microfluidic mixing for the controlled synthesis of two types of limit size lipid nanoparticle (LNP) systems, having either polar or nonpolar cores. Specifically, limit size LNP consisting of 1-palmitoyl, 2-oleoyl phosphatidylcholine (POPC), cholesterol and the triglyceride triolein were synthesized by mixing a stream of ethanol containing dissolved lipid with an aqueous stream, employing a staggered herringbone micromixer. Millisecond mixing of aqueous and ethanol streams at high flow rate ratios (FRR) was used to rapidly increase the polarity of the medium, driving bottom-up synthesis of limit size LNP systems by spontaneous assembly. For POPC/triolein systems the limit size structures consisted of a hydrophobic core of triolein surrounded by a monolayer of POPC where the diameter could be rationally engineered over the range 20-80 nm by varying the POPC/triolein ratio. In the case of POPC and POPC/cholesterol (55/45; mol/mol) the limit size systems achieved were bilayer vesicles of approximately 20 and 40 nm diameter, respectively. We further show that doxorubicin, a representative weak base drug, can be efficiently loaded and retained in limit size POPC LNP, establishing potential utility as drug delivery systems. To our knowledge this is the first report of stable triglyceride emulsions in the 20-50 nm size range, and the first time vesicular systems in the 20-50 nm size range have been generated by a scalable manufacturing method. These results establish microfluidic mixing as a powerful and general approach to access novel LNP systems, with both polar or nonpolar core structures, in the sub-100 nm size range.

[1]  P. Shelat,et al.  Nanoemulsion: A pharmaceutical review , 2010 .

[2]  Suzanne M D'Addio,et al.  Controlling drug nanoparticle formation by rapid precipitation. , 2011, Advanced drug delivery reviews.

[3]  Y. Koyanagi,et al.  Direct measurement of the extravasation of polyethyleneglycol-coated liposomes into solid tumor tissue by in vivo fluorescence microscopy , 1996 .

[4]  G. Radda,et al.  Differential scanning calorimetry and 31P NMR studies on sonicated and unsonicated phosphatidylcholine liposomes. , 1975, Biochimica et biophysica acta.

[5]  Warren C W Chan,et al.  Mediating tumor targeting efficiency of nanoparticles through design. , 2009, Nano letters.

[6]  S. Quake,et al.  Microfluidics: Fluid physics at the nanoliter scale , 2005 .

[7]  S. Quake,et al.  Dynamic pattern formation in a vesicle-generating microfluidic device. , 2001, Physical review letters.

[8]  M. Bally,et al.  Uptake of adriamycin into large unilamellar vesicles in response to a pH gradient. , 1986, Biochimica et biophysica acta.

[9]  S M Gruner,et al.  Doxorubicin physical state in solution and inside liposomes loaded via a pH gradient. , 1998, Biochimica et biophysica acta.

[10]  T. Tadros,et al.  Formation and stability of nano-emulsions. , 2004, Advances in colloid and interface science.

[11]  Joseph R. Robinson,et al.  Effect of size and surface properties of biodegradable PLGA-PMA: PLA:PEG nanoparticles on lymphatic uptake and retention in rats , 2008 .

[12]  M. Bally,et al.  Production of large unilamellar vesicles by a rapid extrusion procedure: characterization of size distribution, trapped volume and ability to maintain a membrane potential. , 1985, Biochimica et biophysica acta.

[13]  John F. Nagle,et al.  Structure of Fully Hydrated Fluid Phase Lipid Bilayers with Monounsaturated Chains , 2006, The Journal of Membrane Biology.

[14]  L. J. Lee,et al.  Ultrasound-enhanced microfluidic synthesis of liposomes. , 2010, Anticancer research.

[15]  O Sonneville-Aubrun,et al.  Nanoemulsions: a new vehicle for skincare products. , 2004, Advances in colloid and interface science.

[16]  Wyatt N Vreeland,et al.  Microfluidic mixing and the formation of nanoscale lipid vesicles. , 2010, ACS nano.

[17]  K. Miyajima,et al.  Phospholipid monolayers at the triolein-saline interface: production of microemulsion particles and conversion of monolayers to bilayers. , 1990, Biochemistry.

[18]  R. Jain,et al.  Delivering nanomedicine to solid tumors , 2010, Nature Reviews Clinical Oncology.

[19]  H. Maeda,et al.  Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review. , 2000, Journal of controlled release : official journal of the Controlled Release Society.

[20]  H. Stone,et al.  Formation of dispersions using “flow focusing” in microchannels , 2003 .

[21]  M. Johnston,et al.  Therapeutically optimized rates of drug release can be achieved by varying the drug-to-lipid ratio in liposomal vincristine formulations. , 2006, Biochimica et biophysica acta.

[22]  Heike Bunjes,et al.  Cryogenic transmission electron microscopy (cryo-TEM) for studying the morphology of colloidal drug delivery systems. , 2011, International journal of pharmaceutics.

[23]  G. Radda,et al.  Outside-inside distributions and sizes of mixed phosphatidylcholine-cholesterol vesicles. , 1976, Biochimica et biophysica acta.

[24]  Vittorio Cristini,et al.  Design of microfluidic channel geometries for the control of droplet volume, chemical concentration, and sorting. , 2004, Lab on a chip.

[25]  P. Constantinides,et al.  Advances in lipid nanodispersions for parenteral drug delivery and targeting. , 2008, Advanced drug delivery reviews.

[26]  Kazunori Kataoka,et al.  Improvement of cancer-targeting therapy, using nanocarriers for intractable solid tumors by inhibition of TGF-β signaling , 2007, Proceedings of the National Academy of Sciences.

[27]  Minoru Seki,et al.  Prediction of Droplet Diameter for Microchannel Emulsification , 2002 .

[28]  Rustem F Ismagilov,et al.  Formation of droplets of alternating composition in microfluidic channels and applications to indexing of concentrations in droplet-based assays. , 2004, Analytical chemistry.

[29]  D. Papahadjopoulos,et al.  Optimizing liposomes for delivery of chemotherapeutic agents to solid tumors. , 1999, Pharmacological reviews.

[30]  P. Cullis Lateral diffusion rates of phosphatidylcholine in vesicle membranes: Eeffects of cholesterol and hydrocarbon phase transitions , 1976, FEBS letters.

[31]  Ching-Hsien Huang,et al.  Phosphatidylcholine vesicles. Formation and physical characteristics , 1969 .

[32]  Hemant Sarin,et al.  Physiologic upper limits of pore size of different blood capillary types and another perspective on the dual pore theory of microvascular permeability , 2010, Journal of angiogenesis research.

[33]  Joseph E. Reiner,et al.  Preparation of nanoparticles by continuous-flow microfluidics , 2008 .

[34]  P. Uster,et al.  Pegylated liposomal doxorubicin (DOXIL®, CAELYX®) distribution in tumour models observed with confocal laser scanning microscopy , 1998 .

[35]  Wyatt N Vreeland,et al.  Microfluidic directed formation of liposomes of controlled size. , 2007, Langmuir : the ACS journal of surfaces and colloids.

[36]  M. Bally,et al.  Influence of pH gradients on the transbilayer transport of drugs, lipids, peptides and metal ions into large unilamellar vesicles. , 1997, Biochimica et biophysica acta.

[37]  Feng Liu,et al.  Long-Circulating Emulsions (Oil-in-Water) as Carriers for Lipophilic Drugs , 1995, Pharmaceutical Research.

[38]  Toshiro Higuchi,et al.  Droplet formation in a microchannel network. , 2002, Lab on a chip.

[39]  Norbert Maurer,et al.  Development of a weak-base docetaxel derivative that can be loaded into lipid nanoparticles. , 2010, Journal of controlled release : official journal of the Controlled Release Society.

[40]  M. Dewhirst,et al.  Tumor vascular permeability, accumulation, and penetration of macromolecular drug carriers. , 2006, Journal of the National Cancer Institute.

[41]  A. Gabizon,et al.  Liposomal Drug Carrier Systems in Cancer Chemotherapy: Current Status and Future Prospects , 2002, Journal of drug targeting.

[42]  E. Korn,et al.  Single bilayer liposomes prepared without sonication. , 1973, Biochimica et biophysica acta.

[43]  K. Edwards,et al.  Formation of drug-arylsulfonate complexes inside liposomes: a novel approach to improve drug retention. , 2006, Journal of controlled release : official journal of the Controlled Release Society.

[44]  I. Mezić,et al.  Chaotic Mixer for Microchannels , 2002, Science.

[45]  B. Lundberg,et al.  Preparation of drug-carrier emulsions stabilized with phosphatidylcholine-surfactant mixtures. , 1994, Journal of pharmaceutical sciences.

[46]  P. Choyke,et al.  Clearance properties of nano-sized particles and molecules as imaging agents: considerations and caveats. , 2008, Nanomedicine.

[47]  L. Mayer,et al.  Solute distributions and trapping efficiencies observed in freeze-thawed multilamellar vesicles. , 1985, Biochimica et biophysica acta.

[48]  M. Uesaka,et al.  Accumulation of sub-100 nm polymeric micelles in poorly permeable tumours depends on size. , 2011, Nature nanotechnology.

[49]  M J Hawkins,et al.  Abraxane, a novel Cremophor-free, albumin-bound particle form of paclitaxel for the treatment of advanced non-small-cell lung cancer. , 2006, Annals of oncology : official journal of the European Society for Medical Oncology.

[50]  J. Hamilton Interactions of triglycerides with phospholipids: incorporation into the bilayer structure and formation of emulsions. , 1989, Biochemistry.

[51]  Robert Langer,et al.  Single-step assembly of homogenous lipid-polymeric and lipid-quantum dot nanoparticles enabled by microfluidic rapid mixing. , 2010, ACS nano.